Market Cap 77.46M
Revenue (ttm) 124.96M
Net Income (ttm) -21.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -17.27%
Debt to Equity Ratio 0.42
Volume 135,400
Avg Vol 233,512
Day's Range N/A - N/A
Shares Out 96.24M
Stochastic %K 35%
Beta 0.34
Analysts Sell
Price Target $2.70

Company Profile

Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut sy...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 224 419 7106
Fax: 510 744 8001
Address:
100 South Saunders Road, Suite 300, Lake Forest, United States
zpapanian
zpapanian Sep. 9 at 6:39 PM
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 8 at 3:35 PM
$ASRT MAKING THIS 0.8 A PARABOLIC ATTACHMENT FOR MARKETS AND ANOTHER STOCK
2 · Reply
Itzdino
Itzdino Sep. 6 at 12:23 AM
$ASRT sending goodvibes!
0 · Reply
EMINENZ
EMINENZ Sep. 3 at 4:57 PM
$ASRT next ER should push us above 1$. Buy and wait.
0 · Reply
bambus3001
bambus3001 Sep. 3 at 10:18 AM
$ASRT Spektrum ++++ 👍👍👍👍
0 · Reply
Kelvin6024
Kelvin6024 Sep. 3 at 9:45 AM
0 · Reply
Chuckuk
Chuckuk Sep. 3 at 8:18 AM
$ASRT What to we shareholders think about Otrexup? Is this the first time we have even heard we should drop it and now it is done. It was a $40M experiment but were there any warranties? Were we knowingly sold a pup? or did we simply mishandle the product? It was our money and their investment. Hmmmm sounds like when you read the reasons to purchase we were subject to some truth stretching so what do we do? I address the Board here and say it is disgraceful that you do not engage with us tell us how sales are going monthly, let us know what happened and also why, with Otrexup when we paid around 50% of our current market cap did we not hear any issues. We are your partners, as shareholders, and vice versa please wake up and engage. Brendan you have know Otrexup well what do you say? TALK TO US!
2 · Reply
Invest2live
Invest2live Sep. 3 at 3:57 AM
$GOSS 178% already. Congrats 🎈🎉🌿 Checkout $ASRT and $LCTX
1 · Reply
Jonnycricket
Jonnycricket Aug. 31 at 5:37 PM
$ASRT I think that the recent firming of the share price reflects the new CEOs willingness to make hard decisions, which is a basic requirement for a turnaround. The previous CEO squandered cash on the Otrexup buyout. There were obviously better opportunities at the time.
1 · Reply
Chuckuk
Chuckuk Aug. 31 at 9:49 AM
$ASRT Looks like that was not such a good deal and the claims seem inflated somewhat!
0 · Reply
Latest News on ASRT
Assertio Holdings, Inc. (ASRT) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 7:41 PM EDT - 4 weeks ago

Assertio Holdings, Inc. (ASRT) Q2 2025 Earnings Call Transcript


Assertio Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 4:05 PM EDT - 4 weeks ago

Assertio Reports Second Quarter 2025 Financial Results


Assertio Holdings, Inc. (ASRT) Q1 2025 Earnings Call Transcript

May 12, 2025, 8:17 PM EDT - 4 months ago

Assertio Holdings, Inc. (ASRT) Q1 2025 Earnings Call Transcript


Assertio Reports First Quarter 2025 Financial Results

May 12, 2025, 4:01 PM EDT - 4 months ago

Assertio Reports First Quarter 2025 Financial Results


Assertio Holdings, Inc. (ASRT) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 6:53 PM EDT - 6 months ago

Assertio Holdings, Inc. (ASRT) Q4 2024 Earnings Call Transcript


Assertio Holdings, Inc. (ASRT) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 6:57 PM EST - 10 months ago

Assertio Holdings, Inc. (ASRT) Q3 2024 Earnings Call Transcript


Assertio Reports Third Quarter 2024 Financial Results

Nov 11, 2024, 4:02 PM EST - 10 months ago

Assertio Reports Third Quarter 2024 Financial Results


Assertio Provides Response to Letter from Short-seller

Nov 11, 2024, 7:30 AM EST - 10 months ago

Assertio Provides Response to Letter from Short-seller


Assertio Reports Second Quarter 2024 Financial Results

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Assertio Reports Second Quarter 2024 Financial Results


Assertio: An Extremely Asymmetric Bet Skewed To The Upside

Jun 27, 2024, 9:51 AM EDT - 1 year ago

Assertio: An Extremely Asymmetric Bet Skewed To The Upside


Assertio Reports First Quarter 2024 Financial Results

May 6, 2024, 4:01 PM EDT - 1 year ago

Assertio Reports First Quarter 2024 Financial Results


zpapanian
zpapanian Sep. 9 at 6:39 PM
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 8 at 3:35 PM
$ASRT MAKING THIS 0.8 A PARABOLIC ATTACHMENT FOR MARKETS AND ANOTHER STOCK
2 · Reply
Itzdino
Itzdino Sep. 6 at 12:23 AM
$ASRT sending goodvibes!
0 · Reply
EMINENZ
EMINENZ Sep. 3 at 4:57 PM
$ASRT next ER should push us above 1$. Buy and wait.
0 · Reply
bambus3001
bambus3001 Sep. 3 at 10:18 AM
$ASRT Spektrum ++++ 👍👍👍👍
0 · Reply
Kelvin6024
Kelvin6024 Sep. 3 at 9:45 AM
0 · Reply
Chuckuk
Chuckuk Sep. 3 at 8:18 AM
$ASRT What to we shareholders think about Otrexup? Is this the first time we have even heard we should drop it and now it is done. It was a $40M experiment but were there any warranties? Were we knowingly sold a pup? or did we simply mishandle the product? It was our money and their investment. Hmmmm sounds like when you read the reasons to purchase we were subject to some truth stretching so what do we do? I address the Board here and say it is disgraceful that you do not engage with us tell us how sales are going monthly, let us know what happened and also why, with Otrexup when we paid around 50% of our current market cap did we not hear any issues. We are your partners, as shareholders, and vice versa please wake up and engage. Brendan you have know Otrexup well what do you say? TALK TO US!
2 · Reply
Invest2live
Invest2live Sep. 3 at 3:57 AM
$GOSS 178% already. Congrats 🎈🎉🌿 Checkout $ASRT and $LCTX
1 · Reply
Jonnycricket
Jonnycricket Aug. 31 at 5:37 PM
$ASRT I think that the recent firming of the share price reflects the new CEOs willingness to make hard decisions, which is a basic requirement for a turnaround. The previous CEO squandered cash on the Otrexup buyout. There were obviously better opportunities at the time.
1 · Reply
Chuckuk
Chuckuk Aug. 31 at 9:49 AM
$ASRT Looks like that was not such a good deal and the claims seem inflated somewhat!
0 · Reply
Chuckuk
Chuckuk Aug. 31 at 9:47 AM
$ASRT https://www.globenewswire.com/news-release/2021/12/15/2353147/0/en/Assertio-Holdings-Inc-Announces-the-Acquisition-of-Otrexup-methotrexate-a-Drug-Device-Combination-from-Antares-Pharma-Inc.html
0 · Reply
Invest2live
Invest2live Aug. 30 at 1:51 AM
$ASRT 28% already; congrats 🎉🎈🎊 Checkout $LCTX
0 · Reply
Invest2live
Invest2live Aug. 29 at 6:44 PM
$ASRT do your DD and get in; speculative but with good potential. Get in below 1 dollar.
0 · Reply
CliffordCapital
CliffordCapital Aug. 29 at 5:42 PM
$ASRT technicals have flipped bullish!! Very good. Algo‘s should keep buying this up.
0 · Reply
D_S
D_S Aug. 29 at 4:58 PM
$ASRT Bumping up again on the ceiling. Needs to break through into the 90s. They have the symposium coming up soon in early/mid-Sept where they will present a poster on Sympazan (something new?). That might be a small catalyst. Doesn't need much imo to get up to the next level.
0 · Reply
BenTen78
BenTen78 Aug. 29 at 4:54 PM
$ASRT cotone!
0 · Reply
Invest2live
Invest2live Aug. 28 at 1:42 PM
$TSLA 127% already; congratulations 🎉🎊🎈 Checkout $TTD and $HEI as well as $LCTX and $ASRT
0 · Reply
CliffordCapital
CliffordCapital Aug. 27 at 9:53 PM
$ASRT golden cross incoming! Give me 1.40$ by year end!
3 · Reply
Kelvin6024
Kelvin6024 Aug. 26 at 12:28 PM
0 · Reply
PriceTact
PriceTact Aug. 23 at 6:08 AM
$ASRT Assertio Holdings is a specialty pharma company facing product competition and legal challenges
3 · Reply
25_usa
25_usa Aug. 23 at 12:49 AM
$ASRT Brandon needs to step up and deliver results for the long-time shareholders who have yet to see returns on their investment. Since his arrival, the company's progress has been stagnant, causing frustration among shareholders. It's essential for Brandon to take his responsibilities seriously and make a positive impact.
1 · Reply
Suckits4
Suckits4 Aug. 20 at 10:15 PM
$ASRT any chance Rolvedon CVR’s pay out this year? Lol
1 · Reply